January 2025 in “Sanjeevani Darshan National Journal of Ayurveda & Yoga” This source examines alopecia areata, an autoimmune condition causing patchy hair loss, describing the current reliance on corticosteroid injections despite their severe side effects, and explores Ayurvedic treatments identified as Shaman and Shodhan for managing an equivalent condition called Indralupta.
23 citations
,
January 2019 in “Journal of wildlife diseases” This study found that a significant number of boreal woodland caribou in NE British Columbia showed symptoms of trace mineral deficiencies and exposure to various pathogens, with substantial winter tick infestations affecting a majority of individuals.
September 2022 in “Hair transplant forum international” This abstract reports on the 2023 Congress of the Brazilian Association of Hair Restoration Surgery held in Rio de Janeiro but provides no new clinical findings or research results.
November 2024 in “DELOS Desarrollo Local Sostenible” In this study, researchers observed that Thunbergia grandiflora and Russelia equisetiformis exhibited mutual aid by altering their phenotypic characteristics to facilitate intertwining, suggesting a form of solidarity without apparent external threats.
9 citations
,
January 2009 in “International Journal of PharmTech Research” This study found that a herbal oil formulation containing Eclipta alba, Hibiscus rosa sinensis, and Nardostachys jatamansi showed better hair growth effects in wister albino rats compared to 2% minoxidil.
JAK inhibitors, like baricitinib and ritlecitinib, show promise in treating alopecia areata effectively and safely.
1 citations
,
November 2017 in “JFL : Jurnal Farmasi Lampung” In this study, researchers found that hair tonic formulations containing Nothopanax scutellarium extract enhanced hair growth in male rabbits over 21 days, with the 25% concentration showing comparable effects to a minoxidil-based positive control.
2 citations
,
October 2020 in “Journal of Investigative Dermatology Symposium Proceedings” This study reports promising preliminary trends in the safety and efficacy of a botanical drug candidate for pediatric alopecia areata, but conclusive results are not yet available.
2 citations
,
June 2018 in “Jurnal Penelitian dan Pengembangan Pertanian” This paper discusses the health benefits and cultivation of new beta-carotene-rich antioxidant maize varieties released by the Ministry of Agriculture, noting their potentially higher yields compared to ordinary corn.
June 2022 in “Zenodo (CERN European Organization for Nuclear Research)” This study evaluated a hydrogel containing extracts from azadirachta indica and tridax procumbens for treating seborrheic dermatitis, finding it passed various tests, including skin irritation and stability, suggesting potential future applications in herbal formulations.
In this study, researchers discovered that the Fusarium sp. strain K23 fungus enhances salt-stress tolerance in Arabidopsis thaliana by promoting root hair development, suggesting a potential strategy to combat soil salinity issues in agriculture.
May 2025 in “Frontiers in Bioinformatics” This study used computational methods to identify six molecules, with jamogenin being particularly promising, that effectively bind to and inhibit the enzyme linked to male pattern hair loss, suggesting these compounds could be explored further for hair growth potential.
April 2020 in “The FASEB journal” In in-vitro experiments, this study found that poncirin showed higher inhibitory activity against JAK3 than tofacitinib, suggesting potential for alopecia areata treatment.
September 2023 in “PubMed” This study reviewed baricitinib's efficacy and safety for treating alopecia areata and found that more patients achieved significant hair regrowth with baricitinib compared to placebo in two phase III trials. Mild to moderate side effects were reported, with additional study suggested for long-term effects.
July 2025 in “International Journal of Pharmaceutical Research and Development” This study evaluated a herbal oil derived from plant extracts for hair growth, finding it significantly accelerated hair growth in an animal model compared to controls, suggesting it as a natural and safe alternative to synthetic treatments with minimized side effects.
May 2026 in “Bulletin of Pharmaceutical Sciences Assiut” This study observed that Globularia alypum L. ointment significantly boosted hair growth in female albino rats, increasing hair length more than the control group after 20 days, without showing toxicity even at high doses.
November 2023 in “JEADV Clinical Practice” In this study, adults with severe alopecia areata experienced greater improvements in hair regrowth, health-related quality of life, and reduced anxiety and depression symptoms after 36 weeks of treatment with baricitinib compared to placebo.
August 2025 in “International Journal of Research in Ayurveda and Pharmacy” In this case study, a 35-year-old woman with persistent hair loss saw noticeable improvements after five weeks of Jalaukavacharana (Leech Therapy) and supportive Ayurvedic treatment, suggesting potential benefits of this approach for hair loss conditions.
January 2024 in “Journal of Clinical Images and Medical Case Reports” This article discusses frontal fibrosing alopecia as a type of Lichen planopilaris marked by gradual hair loss at the front of the scalp but reports no new clinical results.
January 2024 in “International Research Journal of Ayurveda & Yoga” This study reports that in a single-case study, a 24-year-old female with alopecia areata experienced significant hair regrowth after undergoing seven sessions of Jalaukavacharana (leech therapy) along with Ayurvedic medication, suggesting these treatments may be beneficial for such cases.
4 citations
,
July 2012 in “Linguistic Annotation Workshop” This study found that greater root surface area due to root hairs contributed to better growth and zinc uptake of wild-type barley compared to its root-hairless mutant in zinc-deficient soil.
1 citations
,
August 2023 in “JAMA Dermatology” In this study, baricitinib 4 mg led to greater scalp, eyebrow, and eyelash hair regrowth in severe alopecia areata patients than baricitinib 2 mg at weeks 36 and 52.
10 citations
,
June 2021 in “Primates” This study found that wild geladas in Ethiopian crop areas experienced higher levels of human disturbance and health issues, such as increased parasitic infections, compared to those in pasture areas.
March 2026 in “Lithuanian University of Health Sciences” This review concluded that JAK inhibitors are effective in achieving meaningful hair regrowth in moderate to severe alopecia areata, although continuous therapy is often needed to maintain the benefits.
15 citations
,
November 2015 in “Journal of Cosmetic Dermatology” This study reviews existing literature on botanicals for androgenetic alopecia, noting a growing interest and emphasizing research on hair growth stimulants, especially involving green tea and other specific botanicals.
August 2018 in “Cadernos de Agroecologia” This study reported that a new sulfur paste formulation with added plant extract and propolis effectively treated scabies in rabbits by promoting rapid tissue regeneration, hair growth, and eliminating secondary infections, offering a more affordable and less irritating alternative to commercial treatments.
5 citations
,
September 2020 in “Molecules” In this study, extracts from three Polynesian plants—Bidens pilosa, Calophyllum inophyllum, and Fagraea berteroana—were found to increase dermal papilla cell proliferation and modulate hair growth-related gene expression, suggesting potential for stimulating hair growth.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that a hair serum formulated with extracts of Murraya koenigii and Clitoria ternatea demonstrated strong antifungal activity and effective dandruff management, based on laboratory evaluations.
May 2019 in “Journal of clinical oncology” This Phase 1 study reported that topical application of BPM31543 was safe and well-tolerated in patients receiving taxane-based chemotherapy, with some experiencing less than 50% hair loss, suggesting potential efficacy in reducing chemotherapy-induced alopecia, although no maximum tolerated dose was identified.
5 citations
,
December 2023 in “Journal of the European Academy of Dermatology and Venereology”